Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy (CART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02377648
Recruitment Status : Active, not recruiting
First Posted : March 3, 2015
Last Update Posted : May 1, 2018
Sponsor:
Information provided by (Responsible Party):
Flavio Ribichini, Universita di Verona

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2020
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):